Seyed-Mohammad Fereshtehnejad
Overview
Explore the profile of Seyed-Mohammad Fereshtehnejad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
165
Citations
7667
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Eissazade N, Eghdami S, Rohani M, Ajdari A, Fereshtehnejad S, Fasano A, et al.
Neuromodulation
. 2025 Mar;
PMID: 40057881
Background: While pharmacologic interventions remain the mainstay of Parkinson's disease (PD) treatment, alternative approaches such as vagus nerve stimulation (VNS) have drawn attention for their potential in managing PD symptoms....
2.
Fereshtehnejad S, Keshavjee K, Zavar A
Stud Health Technol Inform
. 2025 Feb;
322:87-88.
PMID: 39968562
The Personalized Multi-Domain Digital Platform for Dementia Prevention (PM(DP)*2) is a conceptualized evidence-based initiative designed to reduce dementia burden through tailored interventions. By collecting and analyzing multidimensional data on modifiable...
3.
Fereshtehnejad S
Can J Neurol Sci
. 2025 Feb;
:1-5.
PMID: 39935346
Neurology faces prolonged wait times in Canada, with delays worsened by the COVID-19 pandemic. As neurological disease prevalence rises, ensuring adequate access to care is essential. This study analyzes the...
4.
Thebault S, Fereshtehnejad S, Bergman H, Breville G, Abdoli M, Booth R, et al.
Sci Rep
. 2024 Nov;
14(1):29135.
PMID: 39587121
Our objective was to evaluate the individual and combined prognostic attributes of baseline serum and CSF measurements of Neurofilament light chain (sNfL, cNfL) and glial fibrillary acidic protein (sGFAP, cGFAP)...
5.
Yazdanpanah N, Sedikides C, Ochs H, Camargo Jr C, Darmstadt G, Cerda A, et al.
Adv Exp Med Biol
. 2024 Sep;
1457:1-31.
PMID: 39283418
Coronavirus disease 2019 (COVID-19) has affected not only individual lives but also the world and global systems, both natural and human-made. Besides millions of deaths and environmental challenges, the rapid...
6.
Kopec J, Pourmalek F, Adeyinka D, Adibi A, Agarwal G, Alam S, et al.
Can J Public Health
. 2024 Feb;
115(2):259-270.
PMID: 38361176
Objective: Monitoring trends in key population health indicators is important for informing health policies. The aim of this study was to examine population health trends in Canada over the past...
7.
Transitioning from Subtyping to Precision Medicine in Parkinson's Disease: A Purpose-Driven Approach
Marras C, Fereshtehnejad S, Berg D, Bohnen N, Dujardin K, Erro R, et al.
Mov Disord
. 2024 Jan;
39(3):462-471.
PMID: 38243775
The International Parkinson and Movement Disorder Society (MDS) created a task force (TF) to provide a critical overview of the Parkinson's disease (PD) subtyping field and develop a guidance on...
8.
Fereshtehnejad S, Lokk J
Healthcare (Basel)
. 2023 Dec;
11(24).
PMID: 38132077
Teleneurology is a specialist field within the realm of telemedicine, which is dedicated to delivering neurological care and consultations through virtual encounters. Teleneurology has been successfully used in acute care...
9.
Xu B, Fereshtehnejad S, Zeighami Y
Front Neurosci
. 2023 Oct;
17:1295344.
PMID: 37829722
No abstract available.
10.
Fereshtehnejad S, Ruel M, Bourque P, Warman-Chardon J, Kontolemos M, Zwicker J
Can J Neurol Sci
. 2023 Jun;
51(3):463-465.
PMID: 37272520
No abstract available.